Evidence-based·Updated November 14, 2026·How we grade evidence

Tacrolimus

MedicationTransplant immunosuppressant (prescription)

Tacrolimus is a standard anti-rejection drug after kidney, liver, heart and lung transplants. Compared with cyclosporine, it reduced rejection and graft loss after kidney transplant and reduced deaths and graft loss after liver transplant in pooled trials, at the cost of more new diabetes. Several supplements and foods change its blood level, including St. John's wort, CBD, grapefruit and pomelo.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Organ transplant recipients, as part of a combination prescribed and monitored by a transplant team

Common dosing range

Set by the transplant team and adjusted to whole-blood trough levels. Prograf label starting doses range from 0.075 to 0.2 mg/kg a day in two doses every 12 hours, depending on the organ and other drugs

When to expect effects

Works from the first doses; blood levels are checked often in the first weeks and after any change in medicines or diet

Watch out for

Its blood level shifts easily with other drugs, supplements and foods; too low risks rejection and too high harms the kidneys and nerves. It also commonly lowers magnesium (34 percent of kidney patients on Prograf with azathioprine in one trial) and can raise potassium. Do not add a magnesium or potassium supplement on your own; ask your transplant team whether your levels need treatment.

What is it

Tacrolimus is a prescription immunosuppressant, a calcineurin inhibitor, taken after an organ transplant to stop the immune system from rejecting the new organ. Prograf (capsules, granules for oral suspension and an injection) is labeled for kidney, liver, heart and lung transplants; the once-daily extended-release products Envarsus XR and Astagraf XL are labeled for kidney transplants. Immediate-release and extended-release forms are not interchangeable, and a transplant team adjusts the dose to blood levels. This page covers tacrolimus taken by mouth or vein; tacrolimus ointment for eczema is a different product.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have received a kidney, liver, heart or lung transplant and your transplant team prescribes tacrolimus as part of your anti-rejection regimen (with a prescriber)
You can keep regular blood tests for tacrolimus levels, kidney function, blood sugar and electrolytes on the schedule your transplant team sets
You are willing to check every new medicine, supplement, herbal product and major diet change with your transplant team or pharmacist first

Probably skip if…

You are allergic to tacrolimus, or to the castor oil derivative in the injection (label contraindications)
You have congenital long QT syndrome: the label says to avoid it
You want to switch between Prograf and an extended-release tacrolimus, or between brands, on your own: changes must be supervised because the forms are not interchangeable

Evidence at a glance

preventing rejection after kidney transplant

Good Evidence
Effect
About 44 percent less graft loss at 6 months and 31 percent less acute rejection at 1 year than cyclosporine
Best fit
Adult kidney transplant recipients
Time
From the first months after transplant

survival and graft survival after liver transplant

Good Evidence
Effect
About 15 percent fewer deaths and 27 percent fewer graft losses at 1 year than cyclosporine
Best fit
Adults receiving a first liver transplant
Time
First year after transplant

Evidence for 2 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

preventing rejection after kidney transplant

Disease adjunct
Good Evidence

A meta-analysis of 30 randomized trials (4,102 kidney transplant recipients) compared tacrolimus with cyclosporine as the main anti-rejection drug. Tacrolimus reduced graft loss at 6 months (relative risk 0.56), an effect that lasted up to 3 years, and reduced acute rejection at 1 year (relative risk 0.69) and steroid-resistant rejection (0.49). It caused more insulin-requiring diabetes (relative risk 1.86), tremor, headache and stomach upset. The authors estimated that treating 100 recipients with tacrolimus instead of cyclosporine for a year avoids 12 acute rejections and 2 graft losses but causes 5 extra cases of insulin-dependent diabetes. In the later ELITE-Symphony trial of 1,645 kidney recipients, a low-dose tacrolimus regimen had the best kidney function at 12 months, the fewest biopsy-proven rejections (12.3 percent versus 24.0 to 37.2 percent) and the highest graft survival (94.2 percent) among four regimens.

Effect size
About 44 percent less graft loss at 6 months and 31 percent less acute rejection at 1 year than cyclosporine
Time to effect
From the first months after transplant
Best fit
Adult kidney transplant recipients
Less likely
People at high risk of diabetes, in whom the trade-off is less favorable

Bottom line: Fewer rejections and graft losses than cyclosporine after kidney transplant, with more new diabetes.

survival and graft survival after liver transplant

Disease adjunct
Good Evidence

A Cochrane review of 16 randomized trials (3,813 first-time liver transplant recipients) compared tacrolimus with cyclosporine. At 1 year, tacrolimus reduced death (relative risk 0.85), graft loss (0.73), acute rejection (0.81) and steroid-resistant rejection (0.54), but caused more new insulin-requiring diabetes (1.38). Fewer patients stopped tacrolimus than cyclosporine. Per 100 patients treated with tacrolimus instead of cyclosporine, the reviewers estimated 2 fewer deaths, 5 fewer graft losses and 9 fewer acute rejections, but 4 more cases of diabetes.

Effect size
About 15 percent fewer deaths and 27 percent fewer graft losses at 1 year than cyclosporine
Time to effect
First year after transplant
Best fit
Adults receiving a first liver transplant
Less likely
People at high risk of diabetes, in whom the trade-off is less favorable

Bottom line: After liver transplant, tacrolimus improved survival and graft survival over cyclosporine.

How it works

Tacrolimus binds a protein inside T cells and blocks calcineurin, an enzyme the cells need to switch on and make interleukin-2 and other signals. Without that signal, T cells cannot organize an attack on the transplanted organ. Tacrolimus is given with other immunosuppressants, such as mycophenolate and steroids. Tacrolimus has a narrow therapeutic range: too little risks rejection, too much harms the kidneys and nerves. It is broken down mainly by the CYP3A enzymes in the gut wall and liver and pumped out of gut cells by P-glycoprotein. Anything that blocks these systems (grapefruit, pomelo, CBD, some antibiotics and antifungals) can raise levels, and anything that speeds them up (St. John's wort, rifampin, some seizure drugs) can lower them. That is why supplements and some fruits matter so much with this drug.

How to take it

1. Typical dose
Your transplant team sets and adjusts the dose to your blood levels. Prograf capsule starting doses in the label are 0.1 to 0.2 mg/kg a day after kidney transplant, 0.10 to 0.15 mg/kg a day after liver transplant, and 0.075 mg/kg a day after heart or lung transplant, divided into two doses every 12 hours. Labeled trough targets differ by organ and time since transplant, for example 4 to 11 ng/mL in months 1 to 12 after kidney transplant with mycophenolate. African-American patients may need higher doses.
2. Higher studied dose
Doses are not fixed; the label targets blood levels, and levels above the range are linked to kidney damage, neurotoxicity and QT prolongation.
3. Timing
Prograf: twice daily, about 12 hours apart, at consistent times. Envarsus XR: once daily on an empty stomach at the same time, preferably in the morning. Astagraf XL: every morning on an empty stomach, at least 1 hour before or 2 hours after a meal.
4. With food
Food lowers tacrolimus absorption, so take Prograf consistently either with or without food, and take the extended-release forms on an empty stomach as labeled. Avoid grapefruit and grapefruit juice; the Envarsus XR label also says to avoid alcohol.
5. Split dosing
Prograf is split into two daily doses; Envarsus XR and Astagraf XL are once daily. Prograf granules are not sprinkled on food.
6. How long to try
Usually for as long as the transplanted organ is in place, with ongoing level checks.

What to track

Tacrolimus trough blood levels on the schedule your transplant team sets, with extra checks after any new drug, supplement or diet change
Kidney function, potassium, magnesium and blood sugar
Blood pressure
Tremor, headache, tingling, confusion or seizures (possible high levels: contact your team promptly)
Fever, chills or other signs of infection
New skin spots, with sun protection and skin checks

Bottom line: Your transplant team sets the dose by blood levels; check every supplement and diet change with them first.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Tremor, headache, tingling and trouble sleepingHigh blood pressureDiarrhea, nausea, constipation and stomach painLow magnesium and high potassium on blood testsHigh blood sugar and high blood fatsSwelling of the legs

Serious risks

Who should avoid it

Pregnancy & breastfeeding

The label says tacrolimus can cause fetal harm: registry and postmarketing data suggest a risk of prematurity, birth defects, low birth weight and fetal distress, and newborns have had kidney problems and high potassium. Tacrolimus passes into breast milk. Female and male patients are advised to discuss family planning and contraception with their transplant team before starting; a pregnancy registry (Transplantation Pregnancy Registry International) follows outcomes. Do not stop tacrolimus because of a pregnancy without your team.

Interactions

St. John's wortCritical

St. John's wort speeds up the CYP3A enzymes that clear tacrolimus. In 10 stable kidney transplant patients, 600 mg a day of St. John's wort extract for 14 days cut tacrolimus exposure by more than half (dose-corrected AUC from 180 to 75.9 ng/mL/h), and the median dose had to rise from 4.5 to 8.0 mg a day to stay in range, then fell again after the herb was stopped. The label lists it as a strong inducer that raises rejection risk. Do not combine them; if you already take it, tell your transplant team before stopping so they can check levels through the change.

Grapefruit and grapefruit juiceHigh

Grapefruit permanently disables the CYP3A enzyme in the gut wall, so more tacrolimus is absorbed; the body needs new enzyme to recover, with a half-life of about 23 hours, so spacing grapefruit away from your dose does not prevent the effect. A kidney transplant patient's tacrolimus level about doubled with no dose change after eating grapefruit, and the Prograf and Envarsus XR labels say to avoid grapefruit and grapefruit juice because high levels raise the risk of neurotoxicity and QT prolongation. If you eat some by mistake, take your next dose as prescribed and tell your transplant team.

PomeloHigh

Pomelo is a grapefruit relative. A published case described a considerable rise in tacrolimus blood level in a kidney transplant recipient after eating pomelo, likely from blocking CYP3A4, P-glycoprotein or both, and the authors advised people on tacrolimus or cyclosporine to avoid pomelo and other grapefruit-related citrus. Ask your transplant team about other bitter citrus, such as Seville orange, before eating it regularly.

CBD (cannabidiol)High

In 12 healthy adults, CBD at 5 mg/kg twice daily for 14 days raised the peak level of a single tacrolimus dose 4.2-fold and total exposure 3.1-fold. The Prograf label now advises close monitoring of tacrolimus levels and possible dose reduction when CBD is used. That trial used a high, prescription-level CBD dose, so the effect of smaller consumer doses is less certain; treat any start, stop or change in a CBD product like a medication change and tell your transplant team first.

Lactobacillus probioticsHigh

Lactobacillus rarely infects healthy people, but it can cause bloodstream infections when the immune system is suppressed. A kidney transplant recipient on tacrolimus, mycophenolate and prednisone developed Lactobacillus rhamnosus bacteremia with septic shock; he had taken a Lactobacillus probiotic for five months, though the strain in his blood differed from the product's strains. Many Lactobacillus strains resist vancomycin, which makes treatment harder. Do not start a probiotic without your transplant team's approval, and report fever or chills promptly.

Other probiotic supplements (Bifidobacterium, Lactococcus, Saccharomyces, probiotic kefir and yogurt drinks)High

Live probiotic organisms can occasionally enter the bloodstream when the immune system is suppressed. In a cluster of 6 children after stem cell transplant, genome sequencing showed that the Lactobacillus in their blood was related to the probiotic they had taken. A hospital case-control study in adults also linked such infections strongly to probiotic use, although they were rare overall. Because tacrolimus suppresses the immune system, review any probiotic with your transplant team before using it.

Schisandra (Wuzhi capsules, schisandra berry)High

Schisandra sphenanthera extract, sold as Wuzhi capsules, blocks the CYP3A enzyme and P-glycoprotein that clear tacrolimus; in 12 healthy men it raised tacrolimus exposure by 164 percent on average, and the label lists it with the strong CYP3A inhibitors. Schisandra chinensis berry supplements have not been tested with tacrolimus in people but contain related CYP3A-blocking lignans. Do not start or stop any schisandra product without your transplant team.

Alcohol (extended-release tacrolimus)High

The Envarsus XR, Astagraf XL and generic tacrolimus extended-release capsule labels tell patients to avoid alcoholic beverages because alcohol may change how fast these extended-release forms release tacrolimus, which the Astagraf XL and generic extended-release capsule labels link to a higher risk of nerve toxicity and QT prolongation. The immediate-release Prograf label has no alcohol warning, and the ointment label notes that alcohol can cause facial flushing. Ask your transplant team what applies to the form you take.

Potassium supplements and potassium salt substitutesHigh

Tacrolimus can raise blood potassium; high potassium was among the most common side effects in the Prograf transplant trials, and the label asks prescribers to monitor potassium and weigh other potassium-raising agents carefully. Potassium supplements and potassium-based salt substitutes add potassium directly, and high potassium is usually silent until it affects the heart. Use them only when your transplant team has ordered them and is checking your levels.

Strong CYP3A inhibitors such as ketoconazole, itraconazole, voriconazole, posaconazole, clarithromycin and ritonavir (drug interaction)High

These drugs can cause a rapid, sharp rise in tacrolimus levels, even after the dose is lowered. The label calls for dose reduction (to one third for voriconazole and posaconazole) and level checks starting within 1 to 3 days. The label also lists Schisandra sphenanthera extracts in this group.

Strong CYP3A inducers such as rifampin, rifabutin, phenytoin, carbamazepine and phenobarbital (drug interaction)High

These drugs lower tacrolimus levels and raise the risk of rejection. The label advises increasing the tacrolimus dose and monitoring trough levels when they are used together.

Live vaccines (drug interaction)High

The label says to avoid live vaccines during tacrolimus treatment, such as intranasal flu, measles-mumps-rubella, varicella, yellow fever, BCG and oral typhoid. Inactivated vaccines may work less well. Ask your transplant team which vaccines you need and when.

Cranberry juice and cranberry extractModerate

Cranberry has been shown to inhibit the gut CYP3A enzyme, which would be expected to raise tacrolimus levels, but a published case report went the other way: a 40-year-old kidney transplant patient taking cranberry extract capsules for urinary infections had low tacrolimus levels that barely rose with a higher dose and returned to range after she stopped the cranberry. The authors found no earlier reports of this pair. Because the direction is unpredictable, talk to your transplant team before starting or stopping cranberry products, and ask about a level check after any change.

Magnesium hydroxide antacids (Milk of Magnesia, some Maalox and Mylanta liquids)Moderate

In a healthy-volunteer study described in the label, a magnesium-aluminum hydroxide antacid raised tacrolimus exposure by 21 percent and lowered its peak by 10 percent, and the label says to monitor levels and lower the dose if needed. In a lab study, magnesium antacids also broke tacrolimus down in simulated stomach fluid, so the effect in a given person is hard to predict. Tell your transplant team about regular use and ask your pharmacist about timing.

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.

Warnings (10)

+ st. john's wort

critical

St. John's wort induces the CYP3A4 enzyme and the P-glycoprotein transporter, which speeds up clearance of tacrolimus and lowers its blood levels, raising the risk of transplant rejection. Stopping the herb lets tacrolimus levels climb back up, which can push them too high if the dose was raised in the meantime; high tacrolimus levels can harm the kidneys.

+ alcohol

high

The labels for the extended-release tacrolimus products (Envarsus XR, Astagraf XL and generic tacrolimus extended-release capsules) tell patients to avoid alcoholic beverages, because alcohol may change how fast tacrolimus is released; the Astagraf XL and generic extended-release capsule labels say it may speed release and raise the risk of serious side effects such as nerve toxicity and QT prolongation. The label for immediate-release Prograf has no alcohol warning, and the tacrolimus ointment label notes that drinking alcohol can make the skin or face flushed and hot. These are label precautions: the labels do not describe a human study measuring how much alcohol changes tacrolimus levels.

+ cbd

high

CBD inhibits CYP3A4, CYP3A5, and P-glycoprotein, the main pathways that clear tacrolimus. Case reports and a controlled pharmacokinetic trial show that adding CBD raises tacrolimus blood levels substantially, risking nephrotoxicity, neurotoxicity, and over-immunosuppression in transplant recipients, while stopping CBD abruptly can let levels crash and risk rejection.

+ lactobacillus

high

Tacrolimus is a calcineurin-inhibitor immunosuppressant used after solid-organ transplant. In immunosuppressed transplant recipients, Lactobacillus probiotic organisms can cross the gut wall and cause bloodstream infection. A published case report describes Lactobacillus rhamnosus bacteremia with septic shock in a kidney transplant patient on tacrolimus, and its authors note only a handful of such cases in transplant recipients. Many Lactobacillus strains are intrinsically vancomycin-resistant, making treatment harder.

See all 10 Tacrolimus interactions →

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

The exact product your team prescribed: Prograf or generic immediate-release tacrolimus (twice daily), or Envarsus XR or Astagraf XL (once daily); the label warns these are not interchangeable
The strength in milligrams on every refill; the label asks patients to learn what their capsules or tablets look like and to ask if a refill looks different
When considering any supplement, a full ingredient list you can show your transplant pharmacist, since blends may hide St. John's wort, CBD, Schisandra or probiotics

Be skeptical of…

"Immune boosting" supplements marketed to transplant recipients
Mood, sleep or menopause blends that may contain St. John's wort
CBD products promoted as "natural" and safe with all medicines
Probiotic products sold as safe for everyone, including people on immunosuppressants
Any product or advice suggesting you can lower or stop tacrolimus on your own

Frequently asked questions

Can I take St. John's wort with tacrolimus?⌄

No. In kidney transplant patients, two weeks of St. John's wort cut tacrolimus exposure by more than half, and the label lists it with drugs that raise the risk of rejection. If you are already taking it, do not just stop: tell your transplant team, because your tacrolimus level can climb again after the herb is stopped and they may need to adjust your dose and check levels.

Is grapefruit really a problem with tacrolimus?⌄

Yes. The labels say to avoid grapefruit and grapefruit juice, because grapefruit disables the gut enzyme that limits tacrolimus absorption and the effect lasts long after you eat it, so spacing it from your dose does not help. A kidney transplant patient's level about doubled after eating grapefruit. Pomelo has caused the same problem. Sweet oranges are not part of this warning; ask your team about other citrus.

Is CBD safe with tacrolimus?⌄

CBD can raise tacrolimus levels a lot: in a trial in healthy adults, high-dose CBD tripled tacrolimus exposure. The Prograf label advises closer level monitoring and possible dose reduction with CBD. Do not start or stop CBD without telling your transplant team.

Can I take probiotics after a transplant on tacrolimus?⌄

Ask your transplant team first. Probiotic organisms such as Lactobacillus have caused rare but serious bloodstream infections in people with suppressed immune systems, including a kidney transplant patient on tacrolimus. Report fever or chills promptly.

Tacrolimus lowered my magnesium. Should I take a magnesium supplement?⌄

Low magnesium is common on tacrolimus (34 percent of kidney patients in one trial), and your team usually checks it. Do not add a supplement on your own: antacids containing magnesium and aluminum hydroxide raised tacrolimus exposure by 21 percent in a label study, and your team may prefer a specific product and timing. Ask your transplant team whether your level needs treatment.

References by claim

preventing rejection after kidney transplant

Webster et al., 2005 · PMC (2005) link

Ekberg et al., 2007 · PubMed (2007) link

survival and graft survival after liver transplant

Haddad et al., 2006 · PMC (2006) link

Safety

Prograf (tacrolimus) prescribing information · DailyMed (FDA label) link

Astagraf XL (tacrolimus extended-release capsules) prescribing information · DailyMed (FDA label) link

Interaction: St. John's wort

Mai et al., 2003 · PubMed (2003) link

Interaction: Grapefruit and grapefruit juice

Envarsus XR (tacrolimus extended-release tablets) prescribing information · DailyMed (FDA label) link

Zhai et al., 2019 · PubMed (2019) link

Hanley et al., 2011 · PMC (2011) link

Interaction: Pomelo

Egashira et al., 2003 · PubMed (2003) link

Interaction: CBD (cannabidiol)

So et al., 2025 · PMC (2025) link

Interaction: Lactobacillus probiotics

Sendil et al., 2020 · PMC (2020) link

Interaction: Other probiotic supplements (Bifidobacterium, Lactococcus, Saccharomyces, probiotic kefir and yogurt drinks)

Gilliam et al., 2023 · PubMed (2023) link

Tom et al., 2022 · PMC (2022) link

Interaction: Schisandra (Wuzhi capsules, schisandra berry)

Xin et al., 2007 · PMC (2007) link

Interaction: Alcohol (extended-release tacrolimus)

Tacrolimus extended-release capsules prescribing information · DailyMed (FDA label) link

Tacrolimus ointment 0.1% prescribing information · DailyMed (FDA label) link

Interaction: Potassium supplements and potassium salt substitutes

Hoorn et al., 2011 · PMC (2011) link

Klor-Con (potassium chloride) prescribing information · DailyMed (FDA label) link

Interaction: Cranberry juice and cranberry extract

Dave et al., 2016 · PMC (2016) link

Interaction: Magnesium hydroxide antacids (Milk of Magnesia, some Maalox and Mylanta liquids)

Steeves et al., 1991 · PMC (1991) link

Track Tacrolimus with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 14, 2026·Evidence current as of Nov 14, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.